178 related articles for article (PubMed ID: 21219411)
1. Safety, tolerability and pharmacokinetics of an intravenous bolus of sildenafil in patients with pulmonary arterial hypertension.
Vachiery JL; Huez S; Gillies H; Layton G; Hayashi N; Gao X; Naeije R
Br J Clin Pharmacol; 2011 Feb; 71(2):289-92. PubMed ID: 21219411
[TBL] [Abstract][Full Text] [Related]
2. Perioperative sildenafil therapy for pulmonary hypertension in infants undergoing congenital cardiac defect closure.
El Midany AA; Mostafa EA; Azab S; Hassan GA
Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):963-8. PubMed ID: 23985411
[TBL] [Abstract][Full Text] [Related]
3. Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial.
Simonneau G; Rubin LJ; Galiè N; Barst RJ; Fleming TR; Frost AE; Engel PJ; Kramer MR; Burgess G; Collings L; Cossons N; Sitbon O; Badesch DB;
Ann Intern Med; 2008 Oct; 149(8):521-30. PubMed ID: 18936500
[TBL] [Abstract][Full Text] [Related]
4. Summaries for patients. A combination treatment for pulmonary hypertension.
Ann Intern Med; 2008 Oct; 149(8):I-38. PubMed ID: 18936497
[No Abstract] [Full Text] [Related]
5. Noninvasive assessment of acute cardiopulmonary effects of an oral single dose of sildenafil in patients with idiopathic pulmonary hypertension.
Behzadnia N; Najafizadeh K; Sharif-Kashani B; Dameshghi DO; Shahabi P
Heart Vessels; 2010 Jul; 25(4):313-8. PubMed ID: 20676840
[TBL] [Abstract][Full Text] [Related]
6. An in vitro and in vivo comparative study of directly compressed solid dispersions and freeze dried sildenafil citrate sublingual tablets for management of pulmonary arterial hypertension.
Zayed R; Kamel AO; Shukr M; El-Shamy Ael-H
Acta Pharm; 2012 Nov; 62(3):411-32. PubMed ID: 23470352
[TBL] [Abstract][Full Text] [Related]
7. Sildenafil therapy for pulmonary hypertension before and after pediatric congenital heart surgery.
Palma G; Giordano R; Russolillo V; Cioffi S; Palumbo S; Mucerino M; Poli V; Vosa C
Tex Heart Inst J; 2011; 38(3):238-42. PubMed ID: 21720460
[TBL] [Abstract][Full Text] [Related]
8. Ocular safety of sildenafil citrate when administered chronically for pulmonary arterial hypertension: results from phase III, randomised, double masked, placebo controlled trial and open label extension.
Wirostko BM; Tressler C; Hwang LJ; Burgess G; Laties AM
BMJ; 2012 Feb; 344():e554. PubMed ID: 22354598
[TBL] [Abstract][Full Text] [Related]
9. Impact of sildenafil therapy on pulmonary arterial hypertension in adults with congenital heart disease.
Lu XL; Xiong CM; Shan GL; Zhu XY; Wu BX; Wu GH; Liu ZH; Ni XH; Cheng XS; Gu Q; Zhao ZH; Zhang DZ; Li WM; Zhang C; Tian HY; Guo YJ; Guo T; Liu HM; Zhang WJ; Gu H; Huang SA; Chen JY; Wu WF; Huang K; Li JJ; He JG
Cardiovasc Ther; 2010 Dec; 28(6):350-5. PubMed ID: 20637015
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
11. "Out of the blue"-safety and efficacy of pulmonary hypertension treatment in childhood*.
Kraemer U; Wildschuth E; Tibboel D
Pediatr Crit Care Med; 2014 May; 15(4):377-8. PubMed ID: 24801422
[No Abstract] [Full Text] [Related]
12. Impact of first-line sildenafil monotreatment for pulmonary arterial hypertension.
Yanagisawa R; Kataoka M; Taguchi H; Kawakami T; Tamura Y; Fukuda K; Yoshino H; Satoh T
Circ J; 2012; 76(5):1245-52. PubMed ID: 22333215
[TBL] [Abstract][Full Text] [Related]
13. eComment. Further study needed.
Quraishi NN; Lemon TI; Black LF
Interact Cardiovasc Thorac Surg; 2013 Dec; 17(6):968. PubMed ID: 24243943
[No Abstract] [Full Text] [Related]
14. Ivabradine in pulmonary arterial hypertension: can we delay the need for parenteral prostanoid therapy?
Correale M; Montrone D; Ieva R; Di Biase M; Brunetti ND
Clin Res Cardiol; 2013 May; 102(5):391-3. PubMed ID: 23389056
[No Abstract] [Full Text] [Related]
15. Long-term treatment with sildenafil citrate in pulmonary arterial hypertension: the SUPER-2 study.
Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ;
Chest; 2011 Nov; 140(5):1274-1283. PubMed ID: 21546436
[TBL] [Abstract][Full Text] [Related]
16. Oral sildenafil as a rescue therapy in presumed acute pulmonary hypertensive crisis.
Maxted AP; Hill A; Davies P
Pediatrics; 2013 Feb; 131(2):e626-8. PubMed ID: 23296435
[TBL] [Abstract][Full Text] [Related]
17. Acute effect of sildenafil is maintained in pulmonary arterial hypertension patients chronically treated with bosentan.
Hatano M; Yao A; Kinugawa K; Hirata Y; Nagai R
Int Heart J; 2011; 52(4):233-9. PubMed ID: 21828950
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of high dose generic sildenafil in Thai patients with pulmonary arterial hypertension.
Durongpisitkul K; Pornrattanarungsi S; Panjasamanvong P; Chungsomprasong P
J Med Assoc Thai; 2011 Apr; 94(4):421-6. PubMed ID: 21591526
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis.
Clemmesen JO; Giraldi A; Ott P; Dalhoff K; Hansen BA; Larsen FS
World J Gastroenterol; 2008 Oct; 14(40):6208-12. PubMed ID: 18985812
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fasting bioavailability among 100-mg commercial, 100-mg generic, and 50-mg chewable generic sildenafil tablets in healthy male Mexican volunteers: a single-dose, 3-period, crossover study.
Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; García-González A; Ramírez-San Juan E
Clin Ther; 2012 Mar; 34(3):689-98. PubMed ID: 22386826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
